EP0300036A4 - Compositions pharmaceutiques a base de vasopressine. - Google Patents

Compositions pharmaceutiques a base de vasopressine.

Info

Publication number
EP0300036A4
EP0300036A4 EP19880903003 EP88903003A EP0300036A4 EP 0300036 A4 EP0300036 A4 EP 0300036A4 EP 19880903003 EP19880903003 EP 19880903003 EP 88903003 A EP88903003 A EP 88903003A EP 0300036 A4 EP0300036 A4 EP 0300036A4
Authority
EP
European Patent Office
Prior art keywords
vasopressin
pharmaceutical compositions
based pharmaceutical
compositions
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19880903003
Other languages
German (de)
English (en)
Other versions
EP0300036A1 (fr
Inventor
Uwe Schrell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corint Ltd
Original Assignee
Biomed Research Consultants Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomed Research Consultants Ltd filed Critical Biomed Research Consultants Ltd
Publication of EP0300036A1 publication Critical patent/EP0300036A1/fr
Publication of EP0300036A4 publication Critical patent/EP0300036A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP19880903003 1987-01-30 1988-01-27 Compositions pharmaceutiques a base de vasopressine. Withdrawn EP0300036A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US884187A 1987-01-30 1987-01-30
US8841 1987-01-30

Publications (2)

Publication Number Publication Date
EP0300036A1 EP0300036A1 (fr) 1989-01-25
EP0300036A4 true EP0300036A4 (fr) 1989-06-14

Family

ID=21733999

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19880903003 Withdrawn EP0300036A4 (fr) 1987-01-30 1988-01-27 Compositions pharmaceutiques a base de vasopressine.

Country Status (2)

Country Link
EP (1) EP0300036A4 (fr)
WO (1) WO1988005661A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0381345B1 (fr) * 1989-01-30 1994-07-13 Corint, Ltd. Composition aqueuse à base de desmopressine-CMC
DE4229880A1 (de) * 1992-09-04 1994-03-31 Knauf Siegfried Medikament bzw. Medikamentenzusammensetzung
RU2135204C1 (ru) * 1993-06-29 1999-08-27 Ферринг Б.В. Составы для назального введения десмопрессина
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
SE9701162D0 (sv) 1997-03-27 1997-03-27 Karolinska Innovations Ab New use II

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002119A1 (fr) * 1983-11-18 1985-05-23 Ferring Laboratories, Inc. Ddavp antidiuretique et son procede d'utilisation
WO1988001163A1 (fr) * 1986-08-18 1988-02-25 Ferring Ab Gel radioprotecteur topique pour les muqueuses

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB155919A (en) * 1919-09-29 1920-12-29 Eugene Bregeon Temple An improved hydraulic variable speed transmitter
US3679653A (en) * 1968-09-27 1972-07-25 Monsanto Co Hormonally-active reaction product of a polymer with a hormone
US3502545A (en) * 1968-09-27 1970-03-24 Monsanto Co Process for the separation of water-soluble polymeric materials from unbound protein or peptide using semiporous gel
CS171787B1 (fr) * 1973-11-09 1976-11-29
US4093610A (en) * 1977-01-31 1978-06-06 American Home Products Corporation Process for producing triglycyl-lysine vasopressin and intermediates therefor
US4261980A (en) * 1980-05-16 1981-04-14 Vega Laboratories, Inc. Method for prophylaxis and/or treatment of sickle cell disease
US4263283A (en) * 1980-05-16 1981-04-21 Ferring Pharmaceuticals, Inc. Method for prophylaxis and/or treatment of sickle cell disease
US4399125A (en) * 1981-03-24 1983-08-16 Maurice Manning Novel antagonists of the antidiuretic action of arginine vasopressin
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US4649130A (en) * 1984-01-26 1987-03-10 Medical College Of Ohio Novel derivatives of arginine vasopressin antagonists

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002119A1 (fr) * 1983-11-18 1985-05-23 Ferring Laboratories, Inc. Ddavp antidiuretique et son procede d'utilisation
WO1988001163A1 (fr) * 1986-08-18 1988-02-25 Ferring Ab Gel radioprotecteur topique pour les muqueuses

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO8805661A1 *

Also Published As

Publication number Publication date
WO1988005661A1 (fr) 1988-08-11
EP0300036A1 (fr) 1989-01-25

Similar Documents

Publication Publication Date Title
GB2204792B (en) Pharmaceutical composition
GR3002410T3 (en) Pharmaceutical compositions
ZA883212B (en) Pharmaceutical compositions
GB8826321D0 (en) Pharmaceutical compositions
EG18652A (en) Pharmaceutical compositions
GB8804697D0 (en) Pharmaceutical compositions
GB8810716D0 (en) Pharmaceutical compositions
EP0300036A4 (fr) Compositions pharmaceutiques a base de vasopressine.
ZW14688A1 (en) Pharmaceutical compositions
GB8713091D0 (en) Pharmaceutical compositions
ZA882861B (en) Pharmaceutical compositions
GB8827838D0 (en) Pharmaceutical compositions
IE872452L (en) Pharmaceutical formulations.
IE872188L (en) Pharmaceutical compositions
GB8710967D0 (en) Pharmaceutical compositions
IE871692L (en) Pharmaceutical compositions
IE870950L (en) Pharmaceutical compositions
GB8708765D0 (en) Pharmaceutical compositions
GR871629B (en) Pharmaceutical compositions
MW3588A1 (en) Pharmaceutical compositions
GB8708766D0 (en) Pharmaceutical compositions
GB8716783D0 (en) Pharmaceutical compositions
GB8706258D0 (en) Pharmaceutical compositions
GB8716784D0 (en) Pharmaceutical compositions
GB8716380D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19881021

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19890614

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: CORINT LIMITED

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: CORINT LIMITED

17Q First examination report despatched

Effective date: 19901004

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19910215